Literature DB >> 11919622

Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult.

Cornelius Gross1, Xiaoxi Zhuang, Kimberly Stark, Sylvie Ramboz, Ronald Oosting, Lynn Kirby, Luca Santarelli, Sheryl Beck, René Hen.   

Abstract

Serotonin is implicated in mood regulation, and drugs acting via the serotonergic system are effective in treating anxiety and depression. Specifically, agonists of the serotonin1A receptor have anxiolytic properties, and knockout mice lacking this receptor show increased anxiety-like behaviour. Here we use a tissue-specific, conditional rescue strategy to show that expression of the serotonin1A receptor primarily in the hippocampus and cortex, but not in the raphe nuclei, is sufficient to rescue the behavioural phenotype of the knockout mice. Furthermore, using the conditional nature of these transgenic mice, we suggest that receptor expression during the early postnatal period, but not in the adult, is necessary for this behavioural rescue. These findings show that postnatal developmental processes help to establish adult anxiety-like behaviour. In addition, the normal role of the serotonin1A receptor during development may be different from its function when this receptor is activated by therapeutic intervention in adulthood.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11919622     DOI: 10.1038/416396a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  248 in total

1.  Associations between the serotonin-1A receptor C(-1019)G polymorphism and disordered eating symptoms in female adolescents.

Authors:  Se-Won Lim; Juwon Ha; Dong-Won Shin; Hee-Yeon Woo; Kye-Hyun Kim
Journal:  J Neural Transm (Vienna)       Date:  2010-05-09       Impact factor: 3.575

2.  Adenosine, dopamine and serotonin receptors imbalance in lymphocytes of Lesch-Nyhan patients.

Authors:  Marta G García; Juan G Puig; Rosa J Torres
Journal:  J Inherit Metab Dis       Date:  2012-03-09       Impact factor: 4.982

3.  The learned safety paradigm as a mouse model for neuropsychiatric research.

Authors:  Daniela D Pollak; Francisco J Monje; Gert Lubec
Journal:  Nat Protoc       Date:  2010-04-29       Impact factor: 13.491

4.  Cellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice.

Authors:  Emily Freeman-Daniels; Sheryl G Beck; Lynn G Kirby
Journal:  Psychopharmacology (Berl)       Date:  2010-10-28       Impact factor: 4.530

Review 5.  [Emotional dysfunction, psychopathy and cognitive neuroscience. What is new and what are the consequences].

Authors:  H Walter
Journal:  Nervenarzt       Date:  2005-05       Impact factor: 1.214

Review 6.  Genetic approaches for understanding the role of serotonin receptors in mood and behavior.

Authors:  Zoe R Donaldson; Katherine M Nautiyal; Susanne E Ahmari; René Hen
Journal:  Curr Opin Neurobiol       Date:  2013-02-04       Impact factor: 6.627

Review 7.  Perinatal exposure to bisphenol A at the intersection of stress, anxiety, and depression.

Authors:  Kimberly R Wiersielis; Benjamin A Samuels; Troy A Roepke
Journal:  Neurotoxicol Teratol       Date:  2020-04-11       Impact factor: 3.763

8.  Neural mechanisms underlying stress resilience in Ahi1 knockout mice: relevance to neuropsychiatric disorders.

Authors:  A Lotan; T Lifschytz; A Slonimsky; E C Broner; L Greenbaum; S Abedat; Y Fellig; H Cohen; O Lory; G Goelman; B Lerer
Journal:  Mol Psychiatry       Date:  2013-09-17       Impact factor: 15.992

9.  Gene expression differences in mice divergently selected for methamphetamine sensitivity.

Authors:  Abraham A Palmer; Miguel Verbitsky; Rathi Suresh; Helen M Kamens; Cheryl L Reed; Na Li; Sue Burkhart-Kasch; Carrie S McKinnon; John K Belknap; T Conrad Gilliam; Tamara J Phillips
Journal:  Mamm Genome       Date:  2005-05       Impact factor: 2.957

Review 10.  Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.

Authors:  Benjamin Adam Samuels; Indira Mendez-David; Charlène Faye; Sylvain André David; Kerri A Pierz; Alain M Gardier; René Hen; Denis J David
Journal:  Neuroscientist       Date:  2014-12-08       Impact factor: 7.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.